首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1672652

小分子注射剂市场按药物类别、适应症、给药方式、最终用户和地区划分

Small Molecule Injectable Drugs Market, By Drug Class, By Indication, By Mode of Delivery, By End User, By Geography

出版日期: 2025年02月10日 | 出版商:

Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球小分子注射药物市场规模预计为 2,347.4 亿美元，预计到 2032 年将达到 4,104.6 亿美元，2025 年至 2032 年的复合年增长率为 8.3%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	2347.4亿美元
效能资料	从 2020 年到 2024 年	预测期	2025 至 2032 年
预测期：2025-2032年复合年增长率：	8.30%	2032 年价值预测	4104.6亿美元

数字。 2025 年小分子注射药物市场占有率（按地区划分）

慢性病的流行和对药物输送系统的需求不断增加正在推动小分子注射剂市场的发展。小分子药物的分子量较小，且化学和物理特性与生技药品和生物相似药不同。它可以透过多种途径给药，包括静脉注射、肌肉注射和皮下注射。小分子注射剂与传统注射剂的优点包括控制释放、提高稳定性和生物有效性。可注射小分子的各种治疗应用包括癌症、感染疾病、自体免疫疾病和心血管疾病。此外，药物传递技术的进步，特别是难溶性药物和自我管理设备的进步，进一步扩大了该市场的范围。

市场动态：

全球小分子注射药物市场的发展受到各种慢性和危及生命的疾病日益流行的推动，易患此类疾病的老年人口不断增长，以及在某些治疗中人们对注射药物的偏好日益高于口服药物。然而，注射药物核准的严格监管政策和流程、研究、开发和临床试验的高成本以及透过注射的安全问题是限制市场成长的一些因素。市场参与企业有机会提供先进和有针对性的药物输送系统，开发注射选择有限的治疗方法的配方，并专注于拥有大量患者群体的新兴经济体。

本研究的主要特点

本报告对全球小分子注射药物市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球小分子注射药物市场的主要企业根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行分析。

主要公司包括诺华公司、辉瑞公司、太阳製药工业有限公司、默克公司、梯瓦製药工业有限公司、阿拉宾度製药有限公司、百特公司、费森尤斯卡比公司、西普拉公司、迈兰公司、阿斯特捷利康公司、葛兰素史克公司、Hikma Pharmaceuticals PLC、歌礼製药公司和元再生製药公司。

从本报告中获得的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球小分子注射药物市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过用于分析全球小分子注射剂市场的各种策略矩阵来促进决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 234.74 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.30%	2032 Value Projection:	USD 410.46 Bn

The growing prevalence of chronic diseases and rising demand for targeted drug delivery systems are fueling the small molecule injectable drugs market. Small molecule drugs have lower molecular weight and different chemical and physical properties compared to biologics and biosimilars. They can be administered through various routes such as intravenous, intramuscular, and subcutaneous injections. The advantages of small molecule injectable drugs over conventional injectables include controlled release of drugs, improved stability, and enhanced bioavailability. Various therapeutic applications of small molecule injectables include cancer, infectious diseases, autoimmune disorders, and cardiovascular diseases. Additionally, advancements in drug delivery technologies especially for poorly soluble drugs and self-administrable devices are further expanding the scope of this market.

Market Dynamics:

The global small molecule injectable drugs market is driven by the increasing incidence of various chronic and life-threatening conditions, growing geriatric population susceptible to such diseases, and rising preference for injectables over oral drugs in certain therapies. However, stringent regulatory policies and processes for the approval of injectable drugs, high costs associated with R&D and clinical trials, and safety issues related to drug administration through injections are some of the factors restraining the market growth. The market players have opportunities to offer advanced and targeted drug delivery systems, develop formulations for therapies having limited injectable options, and focus on emerging economies with large patient pools.

Key Features of the Study:

This report provides in-depth analysis of the global small molecule injectable drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global small molecule injectable drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Novartis AG, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Baxter, Fresenius Kabi AG, Cipla, Mylan N.V, AstraZeneca, GSK plc, Hikma Pharmaceuticals PLC, Ascletis Pharma Inc., and Regeneron Pharmaceuticals Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global small molecule injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global small molecule injectable drugs market

Market Segmentation

Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Small Molecule Antibiotics
- Chemotherapy Agents
- Skeletal Muscle Relaxants
- Analgesics
- Anticoagulants
- Anticonvulsants
- Antivirals
- Others (Anti-histamines/Anti-allergy, etc.)
Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Pain Management
- Cardiovascular Diseases
- Infectious Diseases
- CNS Diseases
- Others
Mode of Delivery Insights (Revenue, USD Bn, 2020 - 2032)
- Intravenous
- Intramuscular
- Subcutaneous
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Ambulatory Clinics
- Outpatient Facility
- Infusion Therapy Center
- Others (Home Care Settings, etc.)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis AG
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma Ltd.
- Baxter
- Fresenius Kabi AG
- Cipla
- Mylan N.V
- AstraZeneca
- GSK plc
- Hikma Pharmaceuticals PLC
- Ascletis Pharma Inc.
- Regeneron Pharmaceuticals Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Small Molecule Injectable Drugs Market, By Drug Class
- Small Molecule Injectable Drugs Market, By Indication
- Small Molecule Injectable Drugs Market, By Mode of Delivery
- Small Molecule Injectable Drugs Market, By End User
- Small Molecule Injectable Drugs Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Market Trends
Key Developments

4. Small Molecule Injectable Drugs Market, By Drug Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small Molecule Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chemotherapy Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Skeletal Muscle Relaxants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anticoagulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Anti-histamines/Anti-allergy, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Small Molecule Injectable Drugs Market, By Indication, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CNS Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Small Molecule Injectable Drugs Market, By Mode of Delivery, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Small Molecule Injectable Drugs Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Outpatient Facility
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infusion Therapy Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Home Care Settings, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Small Molecule Injectable Drugs Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma Ltd.
Baxter
Fresenius Kabi AG
Cipla
Mylan N.V
AstraZeneca
GSK plc
Hikma Pharmaceuticals PLC
Ascletis Pharma Inc.
Regeneron Pharmaceuticals Inc.

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

小分子注射剂市场按药物类别、适应症、给药方式、最终用户和地区划分